Effect of escitalopram on CCK-4-induced panic disorders in CCK-4-sensitive volunteers.

Trial Profile

Effect of escitalopram on CCK-4-induced panic disorders in CCK-4-sensitive volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Oct 2012

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Panic disorder
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 03 Oct 2012 New trial record
    • 29 Aug 2012 Results published in European Neuropsychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top